Clinical Trial Update: A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 pilot trial assessing tralokinumab in moderate to severe alopecia areata has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: Emma Guttman | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07